Related Experiment Videos
Prothrombin G20210A mutation and sudden death
Thomas A Andrew1, Robert Fairweather
1Office of the Chief Medical Examiner of the State of New Hampshire, Concord, New Hampshire, USA. thomas.andrew@doj.nh.gov
The American Journal of Forensic Medicine and Pathology
|November 25, 2003
Summary
Sudden death in a young male was linked to pulmonary thromboemboli and a prothrombin G20210A mutation. Genetic testing is recommended for unexplained venous thrombosis cases.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Pathology
Background:
- Sudden death in previously healthy individuals necessitates thorough investigation.
- Pulmonary thromboemboli are a significant cause of mortality.
- Hereditary thrombophilia plays a role in venous thromboembolism.
Observation:
- Autopsy revealed bilateral pulmonary thromboemboli and right ventricular dilatation in a 36-year-old male.
- Histology showed chronic pulmonary hypertension and recanalized thrombi, indicating prior thrombotic events.
- Genetic analysis identified heterozygosity for the prothrombin G20210A mutation.
Findings:
- The prothrombin G20210A mutation is a known genetic risk factor for venous thromboembolism.
- This mutation can predispose individuals to recurrent or unprovoked thrombotic events.
- The case highlights a potential link between this mutation and sudden death due to pulmonary embolism.
Implications:
- Genetic screening for prothrombin G20210A mutation should be considered in unexplained deep venous thromboses and pulmonary thromboemboli.
- Early identification of genetic risk factors can guide preventative strategies and anticoagulation therapy.
- This case underscores the importance of evaluating hereditary thrombophilia in young patients with thrombotic events.